BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28052268)

  • 1. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
    Otani K; Tanigawa T; Watanabe T; Shimada S; Nadatani Y; Nagami Y; Tanaka F; Kamata N; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
    Digestion; 2017; 95(1):22-28. PubMed ID: 28052268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSAID enteropathy and bacteria: a complicated relationship.
    Syer SD; Blackler RW; Martin R; de Palma G; Rossi L; Verdu E; Bercik P; Surette MG; Aucouturier A; Langella P; Wallace JL
    J Gastroenterol; 2015 Apr; 50(4):387-93. PubMed ID: 25572030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
    Yoshikawa K; Kurihara C; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Sato H; Narimatsu K; Okada Y; Higashiyama M; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Tajiri H; Hokari R
    J Gastroenterol; 2017 Jan; 52(1):61-71. PubMed ID: 27075753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota.
    Tanigawa T; Watanabe T; Higashimori A; Shimada S; Kitamura H; Kuzumoto T; Nadatani Y; Otani K; Fukunaga S; Hosomi S; Tanaka F; Kamata N; Nagami Y; Taira K; Shiba M; Suda W; Hattori M; Fujiwara Y
    PLoS One; 2021; 16(1):e0245995. PubMed ID: 33507971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents.
    Satoh H; Takeuchi K
    Curr Med Chem; 2012; 19(1):82-9. PubMed ID: 22300080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota in NSAID Enteropathy: New Insights From Inside.
    Wang X; Tang Q; Hou H; Zhang W; Li M; Chen D; Gu Y; Wang B; Hou J; Liu Y; Cao H
    Front Cell Infect Microbiol; 2021; 11():679396. PubMed ID: 34295835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
    Niwa Y; Nakamura M; Ohmiya N; Maeda O; Ando T; Itoh A; Hirooka Y; Goto H
    J Gastroenterol; 2008; 43(4):270-6. PubMed ID: 18458842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells.
    Nagano Y; Matsui H; Shimokawa O; Hirayama A; Tamura M; Nakamura Y; Kaneko T; Rai K; Indo HP; Majima HJ; Hyodo I
    J Physiol Pharmacol; 2012 Apr; 63(2):137-42. PubMed ID: 22653900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of Probiotics.
    Rekatsina M; Paladini A; Cifone MG; Lombardi F; Pergolizzi JV; Varrassi G
    Adv Ther; 2020 May; 37(5):1933-1945. PubMed ID: 32291647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.
    Kurokawa S; Katsuki S; Fujita T; Saitoh Y; Ohta H; Nishikawa K; Sato Y; Sato Y; Ohira K; Yamada M; Kato M
    J Gastroenterol; 2014 Feb; 49(2):239-44. PubMed ID: 23595613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury.
    Xu N; Zhang C; Jing L; Mou S; Cao X; Yu Z
    Int Immunopharmacol; 2021 Jan; 90():107136. PubMed ID: 33218942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of small intestinal mucosal injuries as a result of NSAID administration.
    Fujimori S; Gudis K; Takahashi Y; Seo T; Yamada Y; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    Eur J Clin Invest; 2010 Jun; 40(6):504-10. PubMed ID: 20412292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
    Lanas A; Scarpignato C
    Digestion; 2006; 73 Suppl 1():136-50. PubMed ID: 16498262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
    Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dietary fiber in formation and prevention of small intestinal ulcers induced by nonsteroidal anti-inflammatory drug.
    Satoh H
    Curr Pharm Des; 2010; 16(10):1209-13. PubMed ID: 20166992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processed Aloe vera gel attenuates non-steroidal anti-inflammatory drug (NSAID)-induced small intestinal injury by enhancing mucin expression.
    Kim MW; Kang JH; Shin E; Shim KS; Kim MJ; Lee CK; Yoon YS; Oh SH
    Food Funct; 2019 Sep; 10(9):6088-6097. PubMed ID: 31490512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visible small-intestinal mucosal injury in chronic NSAID users.
    Graham DY; Opekun AR; Willingham FF; Qureshi WA
    Clin Gastroenterol Hepatol; 2005 Jan; 3(1):55-9. PubMed ID: 15645405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent.
    Watanabe T; Higuchi K; Kobata A; Nishio H; Tanigawa T; Shiba M; Tominaga K; Fujiwara Y; Oshitani N; Asahara T; Nomoto K; Takeuchi K; Arakawa T
    Gut; 2008 Feb; 57(2):181-7. PubMed ID: 17639086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of traditional NSAID-induced small intestinal injury: recent preliminary studies using capsule endoscopy.
    Fujimori S; Takahashi Y; Seo T; Gudis K; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    Digestion; 2010; 82(3):167-72. PubMed ID: 20588029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.